SCHEMBL21154945

SCHEMBL21154945

Cc1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)/C(=N/CSCNc3ccc(C#N)c(C(F)(F)F)c3)C2(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 18/20 0.51
GABRP O00591 1/20 0.44
GABRD O14764 1/20 0.44
NR1I2 O75469 1/20 0.44
NR3C1 P04150 1/20 0.44
PGR P06401 1/20 0.44
KLK3 P07288 1/20 0.44
GABRA1 P14867 1/20 0.44
GABRB1 P18505 1/20 0.44
GABRG2 P18507 1/20 0.44
CNR1 P21554 1/20 0.44
TBXA2R P21731 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
GABRA2 P47869 1/20 0.44
GABRB2 P47870 1/20 0.44
GABRA4 P48169 1/20 0.44
GABRE P78334 1/20 0.44
GABRA6 Q16445 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18682743 0.90 AR (0.54) ARGABRPGABRDNR1I2NR3C1
SCHEMBL20003379 0.82 AR (0.53) ARGABRPGABRDNR1I2NR3C1
SCHEMBL20003273 0.81 AR (0.62) ARGABRPGABRDNR1I2NR3C1
SCHEMBL10155477 0.81 AR (0.53) ARGABRPGABRDNR1I2NR3C1
SCHEMBL14389844 0.81 AR (0.53) ARGABRPGABRDNR1I2NR3C1
SCHEMBL18682744 0.79 AR (0.53) ARNR3C1
SCHEMBL1715855 0.77 AR (0.53) ARGABRPGABRDNR1I2NR3C1
SCHEMBL1715853 0.77 AR (0.53) ARGABRPGABRDNR1I2NR3C1
SCHEMBL29508757 0.77 AR (0.53) ARGABRPGABRDNR1I2NR3C1
SCHEMBL20003389 0.77 AR (0.55) ARGABRPGABRDNR1I2NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190210974-A1 DIARYLHYDANTOIN COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190210974-A1 DIARYLHYDANTOIN COMPOUNDS BPHL, AR, SHBG AR 2/4885GABRP 4199/4885GABRD 3464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.